---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-018216"
form_type: "8-K"
ticker: "AFJK"
cik: "0001979005"
company_name: "Aimei Health Technology Co., Ltd."
filed_at: "2026-04-21T23:59:59+00:00"
generated_at: "2026-05-15T05:10:51.120349+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aimei Health receives Nasdaq delisting notice for late 10-K filing

## Summary
- Nasdaq notified Aimei on April 17, 2026 of non-compliance with Listing Rule 5250(c)(1) due to overdue Annual Report for FY2025.
- Annual Report was due March 31, 2026; company filed a 12b-25 extension on April 1, 2026.
- Company has 60 calendar days to file the 10-K or submit a compliance plan; potential grace period up to 180 days from due date.
- No immediate effect on trading, but failure to regain compliance may lead to delisting of AFJK securities.
- Aimei is a blank-check SPAC; late filing raises execution risk for its planned business combination.

## SEC filing metadata
- accession: 0001493152-26-018216
- form_type: 8-K
- ticker: AFJK
- cik: 0001979005
- company_name: Aimei Health Technology Co., Ltd.
- filed_at: 2026-04-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1979005/000149315226018216/0001493152-26-018216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1979005/000149315226018216/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-018216
- JSON: https://secwatch.observer/filing/0001493152-26-018216.json
- Plain text: https://secwatch.observer/filing/0001493152-26-018216.txt

## Source-grounded claims
- claim_id: 1908444ef001ef96f75e89425da4b3a527da9884
  claim: Aimei Health Technology Co., Ltd. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  evidence_excerpt: April 17, 2026, Aimei Health Technology Co., Ltd (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that because the Company had not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “ Annual Report ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission (the “ SEC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1979005/000149315226018216/0001493152-26-018216-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.